share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Jan 9 05:31

Gainers

  • Syra Health (NASDAQ:SYRA) shares rose 21.2% to $1.5 during Monday's after-market session. The market value of their outstanding shares is at $9.6 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 13.15% to $2.58. The market value of their outstanding shares is at $9.3 million.
  • MaxCyte (NASDAQ:MXCT) shares rose 10.23% to $5.06. The company's market cap stands at $524.0 million.
  • Elevation Oncology (NASDAQ:ELEV) shares rose 7.73% to $1.95. The market value of their outstanding shares is at $82.7 million.
  • MSP Recovery (NASDAQ:LIFW) stock increased by 5.82% to $2.0. The market value of their outstanding shares is at $28.8 million.
  • BrainsWay (NASDAQ:BWAY) stock moved upwards by 5.62% to $7.51. The company's market cap stands at $124.8 million.

Losers

  • Synaptogenix (NASDAQ:SNPX) shares declined by 8.5% to $0.23 during Monday's after-market session. The market value of their outstanding shares is at $4.6 million.
  • OKYO Pharma (NASDAQ:OKYO) stock decreased by 7.81% to $1.74. The company's market cap stands at $57.9 million.
  • LumiraDx (NASDAQ:LMDX) shares decreased by 7.5% to $0.01. The market value of their outstanding shares is at $4.7 million.
  • Soligenix (NASDAQ:SNGX) stock decreased by 5.2% to $0.89. The company's market cap stands at $9.2 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock fell 5.14% to $0.19. The market value of their outstanding shares is at $1.8 million.
  • Vigil Neuroscience (NASDAQ:VIGL) stock declined by 4.96% to $3.45. The company's market cap stands at $123.7 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment